Live Analyst Rating Changes 2604 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Shane Storey
CG
Shane Storey
Canaccord Genuity
Wall Street Analyst
Not yet ranked — too few measurable calls.
—
Success Rate
—
Average Return
— vs benchmark

Rating Distribution

77 Buy 16 Hold 0 Sell
Shane's Stock Coverage 29 ratings · 2026-06-25
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return
AU:TLX
Telix Pharmaceuticals
 May 25, 2026 BUY Strong Buy
+62.4% avg upside
13 analysts
$30.00
90.87% Upside
 ·
AU:CSL
CSL
 May 12, 2026 HOLD Strong Buy
+58.6% avg upside
15 analysts
$106.31
9.67% Downside
 ·
AU:RMD
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
 May 03, 2026 BUY Strong Buy
+52.1% avg upside
11 analysts
$44.50
51.91% Upside
 ·
AU:ARX
Aroa Biosurgery Ltd
 May 03, 2026 BUY Strong Buy
+64.7% avg upside
3 analysts
$1.35
130.83% Upside
 ·
AU:COH
Cochlear
Apr 29, 2026 BUY Hold
+52.5% avg upside
15 analysts
$120.00
2.85% Upside
 ·
AU:MVF
Monash IVF Group Ltd
 Apr 29, 2026 HOLD Strong Buy
+37.0% avg upside
7 analysts
$0.86
19.53% Upside
 ·
AU:ACW
Actinogen Medical
Apr 22, 2026 BUY Strong Buy
+150.0% avg upside
1 analyst
$0.08
150.05% Upside
 ·
AU:OCC
Orthocell Ltd
 Apr 20, 2026 BUY Strong Buy
+76.2% avg upside
1 analyst
$1.26
76.24% Upside
 ·
AU:SOM
Somnomed Limited
 Apr 16, 2026 BUY Strong Buy
+85.1% avg upside
1 analyst
$1.00
85.10% Upside
 ·
AU:NAN
Nanosonics Limited
 Mar 04, 2026 BUY Hold
+45.5% avg upside
7 analysts
$5.55
69.41% Upside
 ·
AU:IDX
Integral Diagnostics Ltd.
 Mar 04, 2026 BUY Strong Buy
+58.0% avg upside
12 analysts
$2.57
27.81% Upside
 ·
AU:PNV
Polynovo
Feb 23, 2026 BUY Strong Buy
+90.2% avg upside
5 analysts
$1.58
68.11% Upside
 ·
AU:ACL
Australian Clinical Labs Ltd
 Feb 17, 2026 HOLD Hold
+30.8% avg upside
6 analysts
$2.40
7.10% Upside
 ·
AU:IPD
Impedimed Limited
 Feb 02, 2026 BUY Strong Buy
+1413.3% avg upside
5 analysts
$0.06
1100.02% Upside
 ·
AU:PME
Pro Medicus Limited
 Nov 18, 2025 BUY Strong Buy
+47.8% avg upside
8 analysts
$350.00
89.12% Upside
 ·
AU:M7T
Mach7 Technologies
 Nov 07, 2025 BUY Strong Buy
+259.2% avg upside
5 analysts
$0.80
166.57% Upside
 ·
AU:RHC
Ramsay Health Care
 Oct 03, 2025 HOLD Hold
-3.8% avg upside
14 analysts
$37.00
13.28% Downside
 ·
AU:CUV
Clinuvel Pharmaceuticals
Sep 24, 2025 BUY Strong Buy
+192.9% avg upside
3 analysts
$32.84
226.74% Upside
 ·
AU:EBR
EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh
 Sep 11, 2025 BUY Strong Buy
+528.3% avg upside
3 analysts
$2.81
649.41% Upside
 ·
AU:IMM
Immutep Ltd
 Sep 10, 2025 BUY Buy
+1143.8% avg upside
4 analysts
$1.20
2299.97% Upside
 ·
AU:PYC
PYC Therapeutics Limited
 Sep 02, 2025 BUY Strong Buy
+125.0% avg upside
3 analysts
$3.00
95.87% Upside
 ·
AU:NEU
Neuren Pharmaceuticals Limited
 Aug 28, 2025 BUY Strong Buy
+98.0% avg upside
3 analysts
$26.50
107.25% Upside
 ·
AU:CU6
Clarity Pharmaceuticals Ltd.
 Aug 08, 2025 BUY Strong Buy
+225.7% avg upside
2 analysts
$8.50
314.55% Upside
 ·
AU:OPT
Opthea
Mar 24, 2025 HOLD Strong Buy
+2166.6% avg upside
4 analysts
$1.00
66.62% Upside
 ·
AU:MYX
Mayne Pharma Group
 Feb 27, 2025 HOLD Hold
+62.0% avg upside
3 analysts
$7.40
209.00% Upside
 ·
AU:CSX
CleanSpace Holdings Ltd.
 Feb 21, 2023 HOLD Hold
+37.5% avg upside
1 analyst
$0.55
37.48% Upside
 ·
AU:OSL
OncoSil Medical Ltd
 Sep 02, 2022 HOLD Hold
-89.8% avg upside
1 analyst
$0.06
89.78% Downside
 ·
AU:LDX
Lumos Diagnostics Holdings Ltd.
 Aug 29, 2022 HOLD Hold
+423.8% avg upside
1 analyst
$0.55
423.84% Upside
 ·
AU:HXL
Hexima Ltd
 Jun 01, 2022 BUY Strong Buy
+5669.3% avg upside
1 analyst
$0.75
5669.32% Upside
 ·
🔒 24 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Shane Storey — Frequently Asked Questions
How accurate are Shane Storey's stock ratings?
Based on the calls 13Foresight could measure, about —% of Shane's ratings were profitable over a one-year hold, with an average return of —% per rating. We score every analyst the same way, from historical prices.
How is Shane ranked on 13Foresight?
Shane Storey is currently ranked unranked . Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Shane cover?
Shane most recently has ratings on AU:TLX, AU:CSL, AU:RMD, AU:ARX, AU:COH, AU:MVF, AU:ACW, AU:OCC, AU:SOM, AU:NAN, AU:IDX, AU:PNV and 17 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.